| Identification | |
| Name: | 1,3,4-Oxadiazole,2-[1,1'-biphenyl]-4-yl-5-phenyl- |
| Synonyms: | 1,3,4-Oxadiazole,2-(4-biphenylyl)-5-phenyl- (6CI,8CI);2-(4-Biphenyl)-5-phenyl-1,3,4-oxadiazole;2-(4-Biphenylyl)-5-phenyl-1,3,4-oxadiazole;2-(p-Biphenyl)-5-phenyl-1,3,4-oxadiazole;2-Phenyl-5-(4-biphenylyl)-1,3,4-oxadiazole;2-Phenyl-5-(4'-biphenylyl)-1,3,4-oxadiazole;2-Phenyl-5-p-biphenylyl-1,3,4-oxadiazole;2-p-Biphenylyl-5-phenyl-1,3,4-oxadiazole;5-(4'-Biphenylyl)-2-phenyl-1,3,4-oxadiazole;5-p-Biphenylyl-2-phenyl-1,3,4-oxadiazole;NSC 24858;PBD;Phenyl-2-p-biphenylyl-5-oxadiazole-1,3,4; |
| CAS: | 852-38-0 |
| EINECS: | 212-712-0 |
| Molecular Formula: | C20H14N2O |
| Molecular Weight: | 298.34 |
| InChI: | InChI=1/C20H14N2O/c1-3-7-15(8-4-1)16-11-13-18(14-12-16)20-22-21-19(23-20)17-9-5-2-6-10-17/h1-14H |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.172g/cm3 |
| Refractive index: | 1.612 |
| Solubility: | Soluble in toluene and xylene, insoluble in water |
| Appearance: | white fine crystalline powder |
| Safety Data | |
 |
|
